Experimental justification of the use of benzimidazole derivatives as antiasthenic agents after craniocerebral trauma

Zarubina, I.V.; Nurmanbetova, F.N.; Shabanov, P.D.

Eksperimental'naia i Klinicheskaia Farmakologiia 68(3): 46-49

2005


ISSN/ISBN: 0869-2092
PMID: 16047681
Document Number: 589640
Experimental administration of benzimidazole derivatives upon model cranioccrebral trauma favored rapid normalization of the behavior of hypoxia-sensitive animals and prevented from excess activation of lipid peroxidation processes in the brain. It is recommended to use benzimidazole derivatives for the control of free-radical processes and the correction of psychopathologic disorders in cases of post-trauma cerebroasthenia.

Document emailed within 1 workday
Secure & encrypted payments